Djordje Atanackovic
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 42
- Hematopoietic Stem Cell Transplantation 11
- Immunology top 1%
- Immunotherapy and Immune Responses 49
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 24
- Oncology top 1%
- CAR-T cell therapy research 35
- Cancer Immunotherapy and Biomarkers 14
- Behavioral Neuroscience top 5%
- Molecular Biology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 12
- Co-authors
- Tim LuetkensCarsten BokemeyerNicolaus KrögerYanran CaoKatrin BartelsYork HildebrandtGerd RitterLloyd J. Old
- Cited by
- HematologyImmunologyOncology
- Journals
- Proceedings of the National Academy of Sciences (4 papers)Nature Communications (1 paper)Journal of Clinical Oncology (5 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Djordje Atanackovic
139 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 116
- Hematology 1.2k
- Immunology 2.1k
- Oncology 2.1k
- Behavioral Neuroscience 88
- Molecular Biology 1.6k
Countries citing papers authored by Djordje Atanackovic
This map shows the geographic impact of Djordje Atanackovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Djordje Atanackovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Djordje Atanackovic more than expected).
Fields of papers citing papers by Djordje Atanackovic
This network shows the impact of papers produced by Djordje Atanackovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Djordje Atanackovic. The network helps show where Djordje Atanackovic may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Djordje Atanackovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 23 | |
| 8 | 2022 | 25 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2019 | 13 | |
| 13 | 2017 | 15 | |
| 14 | 2017 | 4 | |
| 15 | 2016 | 9 | |
| 16 | 2015 | 51 | |
| 17 | 2013 | 10 | |
| 18 | 2008 | 53 | |
| 19 | 2004 | 148 | |
| 20 | 2003 | 49 |
About Djordje Atanackovic
Djordje Atanackovic is a scholar working on Hematology, Immunology and Oncology, having authored 142 papers that have together received 4.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (49 papers), Multiple Myeloma Research and Treatments (42 papers), CAR-T cell therapy research (35 papers), Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (24 papers), Cancer Immunotherapy and Biomarkers (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). The work is most often cited by research in Hematology (1.2k citations), Immunology (2.1k citations) and Oncology (2.1k citations). Djordje Atanackovic has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Tim Luetkens, Carsten Bokemeyer, Nicolaus Kröger, Yanran Cao, Katrin Bartels, York Hildebrandt, Gerd Ritter, Lloyd J. Old, Sacha Gnjatic and Susanna Hegewisch‐Becker. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.